Virax Biolabs Group Limited
General ticker "VRAX" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $3.2M (TTM average)
Virax Biolabs Group Limited does not follow the US Stock Market performance with the rate: -24.0%.
Estimated limits based on current volatility of 14.7%: low 0.48$, high 0.65$
Factors to consider:
- Total employees count: 5 as of 2022
Short-term VRAX quotes
Long-term VRAX plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.16MM | $0.01MM |
| Operating Expenses | $5.74MM | $6.65MM | $6.17MM |
| Operating Income | $-5.73MM | $-6.50MM | $-6.16MM |
| Non-Operating Income | $0.27MM | $-0.24MM | $-0.04MM |
| Interest Expense | $0.02MM | $0.03MM | $0.06MM |
| R&D Expense | $0.40MM | $1.56MM | $1.78MM |
| Income(Loss) | $-5.46MM | $-6.74MM | $-6.20MM |
| Taxes | $0.00MM | $0.00MM | $-0.14MM |
| Profit(Loss)* | $-5.46MM | $-6.73MM | $-6.06MM |
| Stockholders Equity | $9.13MM | $5.37MM | $5.70MM |
| Inventory | $0.02MM | $0.06MM | $0.09MM |
| Assets | $9.81MM | $5.48MM | $6.43MM |
| Operating Cash Flow | $-4.18MM | $-6.25MM | $-4.56MM |
| Capital expenditure | $0.18MM | $1.16MM | $0.60MM |
| Investing Cash Flow | $-0.18MM | $-1.16MM | $-0.60MM |
| Financing Cash Flow | $13.69MM | $1.65MM | $5.81MM |
| Earnings Per Share** | $-5.13 | $-3.36 | $-1.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.